Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2019 Filed Mar 5, 2019 02:03 UTC |
Adelman MichaelSVP, Commercial Operations
|
GrantStock Option (right to buy) · Derivative | 67,400 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001019056-19-000174 · adelman.xml · derivative · entry 3 Adelman Michael · CIK 0001749435 · SVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,400 Underlying: Common Stock · 67,400 shares Expires 2029-02-28 F2 · derivative.exercise_date: The options vest in three approximately equal annual installments beginning on February 28, 2020. Read SEC document |
| December 06, 2018 Filed Dec 7, 2018 18:28 UTC |
Maddux Randy JoeSVP Operations
|
PurchaseCommon Stock | 5,000 | $2.37 | $11,850.00 |
DisclosureSEC source: 0001019056-18-001118 · white_4.xml · nonDerivative · entry 1 Maddux Randy Joe · CIK 0001683826 · SVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 15:23 UTC |
White Marvin LDirector · President and CEO
|
PurchaseCommon Stock | 10,000 | $2.38 | $23,800.00 |
DisclosureSEC source: 0001019056-18-001110 · white_4.xml · nonDerivative · entry 1 White Marvin L · CIK 0001493324 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,603 F1 · price: The purchase price of $2.38 is reflective of the weighted average purchase price. The prices for the transactions reported on this line range from $2.38 to $2.39. Mr. White undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 20:45 UTC |
Mitchell ShawnteSVP, GC and Corporate Affairs
|
Exercise / conversionRestricted Stock Units · Derivative | 1,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-18-000956 · ownership.xml · derivative · entry 3 Mitchell Shawnte · CIK 0001749432 · SVP, GC and Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,787 Underlying: Common Stock · 1,630 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into shares of the Issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: On August 10, 2015, the reporting person was granted 4,892 restricted stock units. 1,631 shares of common stock underlying the restricted stock units vested on each of August 9, 2016 and August 9, 2017, and 1,630 vested on August 9, 2018. F2 · derivative.expiration_date: On August 10, 2015, the reporting person was granted 4,892 restricted stock units. 1,631 shares of common stock underlying the restricted stock units vested on each of August 9, 2016 and August 9, 2017, and 1,630 vested on August 9, 2018. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 20:45 UTC |
Mitchell ShawnteSVP, GC and Corporate Affairs
|
Tax withholdingCommon Stock | 383 | $4.50 | $1,723.50 |
DisclosureSEC source: 0001019056-18-000956 · ownership.xml · nonDerivative · entry 2 Mitchell Shawnte · CIK 0001749432 · SVP, GC and Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,752 Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 20:45 UTC |
Mitchell ShawnteSVP, GC and Corporate Affairs
|
Exercise / conversionCommon Stock | 1,630 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-18-000956 · ownership.xml · nonDerivative · entry 1 Mitchell Shawnte · CIK 0001749432 · SVP, GC and Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,135 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into shares of the Issuer's common stock on a one-for-one basis. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 22:55 UTC |
Niederhuber JohnDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.49 | $0.00 |
DisclosureSEC source: 0001019056-18-000788 · niederhuber_4.xml · derivative · entry 1 Niederhuber John · CIK 0001501240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-05-31 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on May 31, 2019. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 22:54 UTC |
Kunz Barbara LopezDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.49 | $0.00 |
DisclosureSEC source: 0001019056-18-000786 · kunz_4.xml · derivative · entry 1 Kunz Barbara Lopez · CIK 0001679970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-05-31 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on May 31, 2019. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 22:52 UTC |
Grant Grady IIIDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.49 | $0.00 |
DisclosureSEC source: 0001019056-18-000782 · grant_4.xml · derivative · entry 1 Grant Grady III · CIK 0001679966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-05-31 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on May 31, 2019. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 22:53 UTC |
Harsanyi ZsoltDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.49 | $0.00 |
DisclosureSEC source: 0001019056-18-000784 · harsanyi_4.xml · derivative · entry 1 Harsanyi Zsolt · CIK 0001380184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-05-31 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on May 31, 2019. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 22:49 UTC |
El-Hibri FuadDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.49 | $0.00 |
DisclosureSEC source: 0001019056-18-000780 · elhibri_4.xml · derivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-05-31 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on May 31, 2019. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 22:48 UTC |
Abdun-Nabi DanielDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.49 | $0.00 |
DisclosureSEC source: 0001019056-18-000778 · abdunnabi_4.xml · derivative · entry 1 Abdun-Nabi Daniel · CIK 0001380187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-05-31 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on May 31, 2019. Read SEC document |
| May 21, 2018 Filed May 23, 2018 20:08 UTC |
White Marvin LDirector · President and CEO
|
Exercise / conversionRestricted Unit Stock · Derivative | 35,644 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-18-000739 · white_4.xml · derivative · entry 3 White Marvin L · CIK 0001493324 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,644 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on May 21, 2015. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs fully vested on May 21, 2018. F2 · derivative.expiration_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on May 21, 2015. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs fully vested on May 21, 2018. Read SEC document |
| May 21, 2018 Filed May 23, 2018 20:08 UTC |
White Marvin LDirector · President and CEO
|
Tax withholdingCommon Stock | 8,373 | $5.61 | $46,972.53 |
DisclosureSEC source: 0001019056-18-000739 · white_4.xml · nonDerivative · entry 2 White Marvin L · CIK 0001493324 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,603 Read SEC document |
| May 21, 2018 Filed May 23, 2018 20:08 UTC |
White Marvin LDirector · President and CEO
|
Exercise / conversionCommon Stock | 35,644 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-18-000739 · white_4.xml · nonDerivative · entry 1 White Marvin L · CIK 0001493324 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,976 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| March 19, 2018 Filed Mar 21, 2018 19:15 UTC Amendment |
White Marvin LDirector · President and CEO
|
PurchaseCommon Stock | 100,000 | $2.93 | $293,000.00 |
DisclosureSEC source: 0001019056-18-000465 · white_4a.xml · nonDerivative · entry 1 White Marvin L · CIK 0001493324 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,332 F1 · price: The purchase price of $2.93 is reflective of the weighted average purchase price. The prices for the transactions reported on this line range from $2.865 to $3.020, inclusive. Mr. White undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price. F2 · price: This amendment is being filed to reflect the fact that the reported transaction was a purchase and not a sale of shares of the Issuer by Mr. White. Column 3 of Table I and footnote (1) of this Form 4 as originally filed incorrectly indicated that this transaction was a sale. Those references have been corrected on this amendment to the original Form 4 to reflect that the reported transaction was a purchase. Read SEC document |
| March 19, 2018 Filed Mar 21, 2018 15:57 UTC |
White Marvin LDirector · President and CEO
|
SaleCommon Stock | 100,000 | $2.93 | $293,000.00 |
DisclosureSEC source: 0001019056-18-000463 · white_4.xml · nonDerivative · entry 1 White Marvin L · CIK 0001493324 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,332 F1 · price: The selling price of $2.93 is reflective of the weighted average sale price. The prices for the transactions reported on this line range from $2.865 to $3.020, inclusive. Mr. White undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 10, 2018 Filed Mar 14, 2018 01:37 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,747 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-18-000435 · lamothe_4.xml · derivative · entry 4 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,318 Underlying: Common Stock · 6,747 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F3 · derivative.exercise_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 10, 2015. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016, each RSU was adjusted and assumed by the Issuer. The RSUs fully vested as of March 10, 2018. F3 · derivative.expiration_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 10, 2015. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016, each RSU was adjusted and assumed by the Issuer. The RSUs fully vested as of March 10, 2018. Read SEC document |
| March 10, 2018 Filed Mar 14, 2018 01:37 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
Tax withholdingCommon Stock | 1,583 | $3.13 | $4,954.79 |
DisclosureSEC source: 0001019056-18-000435 · lamothe_4.xml · nonDerivative · entry 2 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,876 Read SEC document |
| March 10, 2018 Filed Mar 14, 2018 01:37 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
Exercise / conversionCommon Stock | 6,747 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-18-000435 · lamothe_4.xml · nonDerivative · entry 1 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| March 09, 2018 Filed Mar 14, 2018 01:36 UTC |
Gross Jane ASee Remarks
|
Exercise / conversionRestricted Stock Unit · Derivative | 9,728 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-18-000433 · gross_4.xml · derivative · entry 4 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,138 Underlying: Common Stock · 9,728 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F3 · derivative.exercise_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 10, 2015. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016, each RSU was adjusted and assumed by the Issuer. The RSUs fully vested as of March 9, 2018. F3 · derivative.expiration_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 10, 2015. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016, each RSU was adjusted and assumed by the Issuer. The RSUs fully vested as of March 9, 2018. Read SEC document |
| March 09, 2018 Filed Mar 14, 2018 01:36 UTC |
Gross Jane ASee Remarks
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 67,400 | $0.00 Strike: $3.13 | $0.00 |
DisclosureSEC source: 0001019056-18-000433 · gross_4.xml · derivative · entry 3 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,400 Underlying: Common Stock · 67,400 shares Expires 2028-03-09 F2 · derivative.exercise_date: On March 9, 2018, the reporting person was granted 67,400 stock options vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 09, 2018 Filed Mar 14, 2018 01:36 UTC |
Gross Jane ASee Remarks
|
Tax withholdingCommon Stock | 2,282 | $3.13 | $7,142.66 |
DisclosureSEC source: 0001019056-18-000433 · gross_4.xml · nonDerivative · entry 2 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,155 Read SEC document |
| March 09, 2018 Filed Mar 14, 2018 01:36 UTC |
Gross Jane ASee Remarks
|
Exercise / conversionCommon Stock | 9,728 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-18-000433 · gross_4.xml · nonDerivative · entry 1 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 21:39 UTC |
Maddux Randy JoeSenior VP, Operations
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 67,400 | $0.00 Strike: $3.13 | $0.00 |
DisclosureSEC source: 0001019056-18-000437 · maddux_4.xml · derivative · entry 1 Maddux Randy Joe · CIK 0001683826 · Senior VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,400 Underlying: Common Stock · 67,400 shares Expires 2028-03-09 F1 · derivative.exercise_date: On March 9, 2018, the reporting person was granted 67,400 stock options vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 09, 2018 Filed Mar 14, 2018 01:41 UTC |
White Marvin LDirector · President and CEO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 151,600 | $0.00 Strike: $3.13 | $0.00 |
DisclosureSEC source: 0001019056-18-000441 · white_4.xml · derivative · entry 1 White Marvin L · CIK 0001493324 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,600 Underlying: Common Stock · 151,600 shares Expires 2028-03-09 F1 · derivative.exercise_date: On March 9, 2018, the reporting person was granted 151,600 stock options vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 09, 2018 Filed Mar 14, 2018 01:40 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
Exercise / conversionRestricted Stock Unit · Derivative | 13,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-18-000439 · stromatt_4.xml · derivative · entry 3 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,269 Underlying: Common Stock · 13,892 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F3 · derivative.exercise_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 10, 2015. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016, each RSU was adjusted and assumed by the Issuer. The RSUs fully vested as of March 9, 2018. F3 · derivative.expiration_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 10, 2015. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016, each RSU was adjusted and assumed by the Issuer. The RSUs fully vested as of March 9, 2018. Read SEC document |
| March 09, 2018 Filed Mar 14, 2018 01:40 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 67,400 | $0.00 Strike: $3.13 | $0.00 |
DisclosureSEC source: 0001019056-18-000439 · stromatt_4.xml · derivative · entry 2 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,400 Underlying: Common Stock · 67,400 shares Expires 2028-03-09 F2 · derivative.exercise_date: On March 9, 2018, the reporting person was granted 67,400 stock options vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 09, 2018 Filed Mar 14, 2018 01:40 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
Exercise / conversionCommon Stock | 13,892 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-18-000439 · stromatt_4.xml · nonDerivative · entry 1 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,737 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| March 09, 2018 Filed Mar 14, 2018 01:37 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 67,400 | $0.00 Strike: $3.13 | $0.00 |
DisclosureSEC source: 0001019056-18-000435 · lamothe_4.xml · derivative · entry 3 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,400 Underlying: Common Stock · 67,400 shares Expires 2028-03-09 F2 · derivative.exercise_date: On March 9, 2018, the reporting person was granted 67,400 stock options vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 01, 2018 Filed Mar 6, 2018 00:37 UTC |
Gross Jane ASee Remarks
|
Exercise / conversionRestricted Stock Unit · Derivative | 9,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-18-000417 · gross_4.xml · derivative · entry 2 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,866 Underlying: Common Stock · 9,140 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vest as follows: 9,140 on March 1, 2017, 9,140 on March 1, 2018 and 9,138 on March 1, 2019. F2 · derivative.expiration_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vest as follows: 9,140 on March 1, 2017, 9,140 on March 1, 2018 and 9,138 on March 1, 2019. Read SEC document |
| March 01, 2018 Filed Mar 6, 2018 00:37 UTC |
Gross Jane ASee Remarks
|
Exercise / conversionCommon Stock | 9,140 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-18-000417 · gross_4.xml · nonDerivative · entry 1 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| March 01, 2018 Filed Mar 6, 2018 00:38 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-18-000418 · lamothe_4.xml · derivative · entry 3 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,065 Underlying: Common Stock · 7,320 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vest as follows: 7,320 on March 1, 2017, 7,320 on March 1, 2018 and 7,318 on March 1, 2019. F2 · derivative.expiration_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vest as follows: 7,320 on March 1, 2017, 7,320 on March 1, 2018 and 7,318 on March 1, 2019. Read SEC document |
| March 01, 2018 Filed Mar 6, 2018 00:38 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
Tax withholdingCommon Stock | 1,717 | $3.04 | $5,219.68 |
DisclosureSEC source: 0001019056-18-000418 · lamothe_4.xml · nonDerivative · entry 2 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,712 Read SEC document |
| March 01, 2018 Filed Mar 6, 2018 00:38 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
Exercise / conversionCommon Stock | 7,320 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-18-000418 · lamothe_4.xml · nonDerivative · entry 1 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| March 01, 2018 Filed Mar 6, 2018 00:36 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
Exercise / conversionRestricted Stock Unit · Derivative | 16,269 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-18-000416 · stromatt_4.xml · derivative · entry 2 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,161 Underlying: Common Stock · 16,269 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vest in three equal annual installments on the anniversary of the grant date. F2 · derivative.expiration_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vest in three equal annual installments on the anniversary of the grant date. Read SEC document |
| March 01, 2018 Filed Mar 6, 2018 00:36 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
Exercise / conversionCommon Stock | 16,269 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-18-000416 · stromatt_4.xml · nonDerivative · entry 1 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| February 03, 2018 Filed Feb 7, 2018 00:22 UTC |
Gross Jane ASee Remarks
|
Exercise / conversionRestricted Stock Unit · Derivative | 18,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-18-000289 · gross_4.xml · derivative · entry 2 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,006 Underlying: Common Stock · 18,136 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: On August 3, 2016, the reporting person was granted 36,271 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018. F2 · derivative.expiration_date: On August 3, 2016, the reporting person was granted 36,271 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018. Read SEC document |
| February 03, 2018 Filed Feb 7, 2018 00:22 UTC |
Gross Jane ASee Remarks
|
Exercise / conversionCommon Stock | 18,136 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-18-000289 · gross_4.xml · nonDerivative · entry 1 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| February 03, 2018 Filed Feb 7, 2018 00:23 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
Exercise / conversionRestricted Stock Unit · Derivative | 27,381 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-18-000291 · stromatt_4.xml · derivative · entry 2 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,430 Underlying: Common Stock · 27,381 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: On August 3, 2016, the reporting person was granted 54,762 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018. F2 · derivative.expiration_date: On August 3, 2016, the reporting person was granted 54,762 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018. Read SEC document |
| February 03, 2018 Filed Feb 7, 2018 00:23 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
Exercise / conversionCommon Stock | 27,381 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-18-000291 · stromatt_4.xml · nonDerivative · entry 1 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| February 03, 2018 Filed Feb 7, 2018 00:21 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
Exercise / conversionRestricted Stock Unit · Derivative | 25,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-18-000287 · lamothe_4.xml · derivative · entry 3 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,385 Underlying: Common Stock · 25,340 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: On August 3, 2016, the reporting person was granted 50,680 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018. F2 · derivative.expiration_date: On August 3, 2016, the reporting person was granted 50,680 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018. Read SEC document |
| February 03, 2018 Filed Feb 7, 2018 00:21 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
Tax withholdingCommon Stock | 7,514 | $3.24 | $24,345.36 |
DisclosureSEC source: 0001019056-18-000287 · lamothe_4.xml · nonDerivative · entry 2 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,109 Read SEC document |
| February 03, 2018 Filed Feb 7, 2018 00:21 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
Exercise / conversionCommon Stock | 25,340 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-18-000287 · lamothe_4.xml · nonDerivative · entry 1 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| November 15, 2017 Filed Dec 8, 2017 18:06 UTC |
Maddux Randy JoeSenior VP, Operations
|
PurchaseCommon Stock | 25,000 | $2.76 | $69,000.00 |
DisclosureSEC source: 0001019056-17-000796 · maddux_4.xml · nonDerivative · entry 1 Maddux Randy Joe · CIK 0001683826 · Senior VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 19:59 UTC |
Gross Jane ASee Remarks
|
Exercise / conversionRestricted Stock Unit · Derivative | 38,093 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-17-000648 · gross_4.xml · derivative · entry 3 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,142 Underlying: Common Stock · 38,093 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: The RSUs were originally issued on August 3, 2016 and fully vested on August 1, 2017. F2 · derivative.expiration_date: The RSUs were originally issued on August 3, 2016 and fully vested on August 1, 2017. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 19:59 UTC |
Gross Jane ASee Remarks
|
Tax withholdingCommon Stock | 10,076 | $1.83 | $18,439.08 |
DisclosureSEC source: 0001019056-17-000648 · gross_4.xml · nonDerivative · entry 2 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,433 Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 19:59 UTC |
Gross Jane ASee Remarks
|
Exercise / conversionCommon Stock | 38,093 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-17-000648 · gross_4.xml · nonDerivative · entry 1 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 20:00 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
Exercise / conversionRestricted Stock Unit · Derivative | 78,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-17-000649 · stromatt_4.xml · derivative · entry 2 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,811 Underlying: Common Stock · 78,123 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: The RSUs were issued on August 3, 2016 and fully vested on August 1, 2017. F2 · derivative.expiration_date: The RSUs were issued on August 3, 2016 and fully vested on August 1, 2017. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 20:00 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
Exercise / conversionCommon Stock | 78,123 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-17-000649 · stromatt_4.xml · nonDerivative · entry 1 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.